In I968 the results of treating 42 eyes from 35 patients suffering from proliferative diabetic retinopathy were presented at the Airlie House Symposium on Diabetic Retinopathy. We have now treated I 74 eyes from I26 consecutive cases and present the results of the series which has now been running for over 7 years. Clinical data (Table I) The series includes 33 out of the original 35 patients reported in I968 at the time of the Airlie House Symposium, and consists of 78 men and 48 women, whose present ages range from 2I to 72 years. For comparison with these cases we have 59 'control' eyes from 42 patients previously documented in the proceedings of the symposium. * These controls were cases studied before the light coagulator was available, and are comparable in terms of sex ratio, age at onset of diabetes, and the length of time they have been observed (Tables I, III, IV) .
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All affected eyes had true new-formed vessels as distinct from dilatations of pre-existing capillary channels, and in all cases these had given rise to subhyaloid or vitreous haemorrhages or occasionally to loss ofvision due to cicatricial changes. The fact that the great majority of these cases were referred by other ophthalmologists probably ensures that we are dealing with a series of cases of at least average severity.
Assessment of patient (a) General assessment It is of paramount importance to have a diabetes specialist's assessment. The cardio-vascular system is examined with particular reference to hypertension, cardiac ischaemia, and the state of the arteries of the extremities, the renal system for evidence of nephropathy, and the peripheral nervous system for evidence of neuropathy. The state of the anatomical retinal vessels is particularly noted. The most striking abnormalities are usually on the venous side of the circulation, and generalized distension, with sectors of beading, sheathing, and displacement of vessels by traction bands are noted. The signs on the arterial side of the circulation are even more ominous and arteriolar narrowing and obliteration by connective tissue (the so-called "white line" appearance) is often present in the third or fourth order branchings and is indicative of retinal ischaemia.
(4) CAPILLARY ANGIOPATHY AND EXUDATIVE MACULOPATHY Foci of capillary pathology, manifested by microaneurysms, varicose capillaries, haemorrhages, retinal oedema, and hard exudates, are indications of capillary angiopathy. They occur principally at the posterior pole, and are especially numerous just lateral to the macula. These lesions, often termed "background retinopathy", are important as they are a frequent cause of visual deterioration, but have been excluded from the series in which the main target of attack has been the proliferative lesions.
(5) HAEMORRHAGES Subhyaloid haemorrhages are of the greatest significance in the ocular assessment in that they betray the presence of actual bleeding sites, the eradication of which is the cardinal aim of this method of treatment. Multiple subhyaloid haemorrhages indicate that several groups of new vessels have ruptured at the same time and this invariably means that the patient had undergone some physical strain.
Vitreous haemorrhages present greater difficulties, but the quadrant from which bleeding occurred can often be found from the history of how it originally appeared to the patient, or by noting the area of greater density of the haemorrhage. Small recurrent vitreous haemorrhages have been a frequent problem. These are often due to a quite insignificant group of new vessels attached to a retracted vitreous face, and painstaking examinations are required to reveal them.
(6) CONNECTIVE TISSUE FORMATIONS These form particularly in the cicatricial stage of evolution and result either from connective tissue condensations around new vessels on the disc or retina or from thickenings of the posterior vitreous face. These may form a barrier to vision, or cause traction effects on the retina, such as schisis, detachment, or displacement of the macula or blood vessels.
The ocular condition was reviewed regularly at intervals of 3 to 4 months and serial fundus photography was used extensively to record pre-and postoperative changes.
Method
There were two major aspects to treatment: (i) All patients, both cases and controls, were advised to modify their mode of life to eliminate as far as possible all situations leading to raised venous pressure in the head and neck. These included lifting and all forms of physical strain, straining at stool, coughing, vomiting, etc. In addition, specific rest in hospital was advised in particular cases in which a vitreous haemorrhage was slow to show signs of absorption, especially if it was the first major haemorrhage.
(2) All patients were treated with photocoagulation on at least one occasion, but the majority had repeated light coagulation as further groups of new vessels developed. So far 63 eyes have required only one light coagulation session, and one eye has had as many as nine treatments; the average number given to the I74 eyes was 2 -2 sessions. The indications for treatment were:
(i) All flat areas of neovascularization, either Stage I or Stage II, which were not on the disc or related to the macula. (ii) Pre-retinal ("forward") groups of vessels, either Stage I or Stage II. However, pre-retinal Stage II vessels were not treated if associated with bands or if it was thought that traction effects on the macula might follow. (iii) Disc vessels were not considered suitable for direct treatment by light coagulation but in some instances regression of disc vessels followed remote peripheral coagulation. This has previously been reported (Taylor, 1970) . (iv) Coagulations were used sparingly in cases in which the "white-line" appearance of the arterioles indicated retinal ischaemia. (v) Stage III lesions were not treated.* A total of I 74 eyes were treated by photocoagulation in the series of I 26 patients, 48 having treatment in both eyes and 78 in one only. In 59 of these 78 patients, the second eye was untreatable when first seen because of retinal detachment, dense vitreous haemorrhage, or terminal Stage III retinopathy. Since the initial photocoagulation eleven eyes have been under observation for more than 5 years and sixteen eyes for less than 6 months (Table II, overleaf) .
Results
(i) Effect of rest in bed 23 patients, I3 male and IO female, were admitted to hospital for rest in bed and limitation of all physical activity. Five of these patients had bilateral vitreous haemorrhages, so that 28 eyes were under observation. After periods of rest varying from 2 weeks to several months in one case, fifteen eyes showed complete clearing of vitreous haemorrhages, although in four there was associated advanced retinopathy so there could be no improvement in visual acuity. In twelve eyes there was no real change in the density of the vitreous haemorrhage either objective or subjective, and one eye had a further vitreous haemorrhage while the patient was in hospital.
(2) Effect of light coagulation Of the many possible parameters by which the effect of treatment can be gauged, the length of time that the original visual acuity is preserved is probably the most satisfactory. Table III , the number of eyes maintaining the original visual acuity is greater than 50 per cent. in all periods except the 7. H. Dobree and Enid Taylor These results may be compared with our control series of 59 eyes, of xvhich only 23 (39 per cent.) retained the original visual acuity.
In groups of eyes observed for 3 years or less, the numbers retaining the same level of vision were very similar, namely 66 per cent. of treated and 56 per cent. of control untreated eyes. In contrast, in those groups under observation for more than 3 years, 50 per cent. of treated eyes as opposed to only 27 per cent. of untreated eyes retained the same visual acuity.
A further comparison can be made between these two groups by considering the number of eyes retaining the same level of vision which have been under observation for more than I year, more than 2 years, and so on up to 5 years, instead of considering them in each separate yearly grouping. The results are shown in Table IV (opposite) and are represented graphically in the Figure. It is seen that at all stages the treated eyes had a much better retention of vision than the controls and that an unexpectedly high number retained the original visual acuity for over 5 years. In both series most failures to maintain the original visual acuity occurred in the first 2 years. The level of visual retention in the I 74 treated eyes was assessed by subdividing the final visual acuity into four groups (Table V) . In addition, each group of levels of retention of visual acuity can be related to age at onset and duration of diabetes as shown in Table VI . In each range the highest number of eyes is that in Group I (i.e. minimum visual acuity 6/9), but if this number is taken as a percentage of the total number of eyes in each age group, a higher proportion of patients with diabetes ofjuvenile onset (63 per cent.) retained 6/9 vision than of those with diabetes of mature onset (35 per cent.). Moreover, there is a trend towards a more rapid loss of vision with late onset diabetes than with early onset diabetes-so that those with a visual acuity of less than 6/60 have 30 years' average duration of diabetes with onset at less than I6 years in contrast to 8 years' average duration with onset at 40 years or over. (C) EFFECT OF DISC NEOVASCULARIZATION (Table VII) Of the I74 eyes, 99 (6o per cent.) had new vessels on the disc, but the retention of the original visual acuity is much the same in these eyes as in those without disc vessels even though a higher proportion of the former has been under observation for more than 3 years. 13 (3) I 2 (I) IV < 6/6o 27 (2I) 7 (7) The numbers in brackets refer to numbers of eyes under observation for more than 3 years.
Thus 47 eyes (47 per cent.) with new vessels on the optic disc and 38 eyes (5I per cent.)
without disc vessels fell into Group I. In contrast, in Group IV (i.e. eyes which are legally blind), there are 27 eyes (27 per cent.) with and only seven eyes (9 per cent.) without disc vessels-in both cases more than three-quarters of the eyes have been under observation for more than 3 years. While many eyes with disc vessels pass into the cicatricial Stage III without bleeding, the occurrence of disc haemorrhage may gravely and permanently influence the prognosis.
(D) VISUAL RETENTION IN TREATED "ONLY EYES"
This is a particularly interesting group of cases in which the eye treated had a potentially bad prognosis, the fellow eye having either been previously blinded by proliferative diabetic retinopathy or considered to be untreatable. There are 42 of these pairs of eyes for study and they have been under observation for from 15 months to 5 years since the first treatment by photocoagulation. Of the 42 untreatable eyes, the vision was less than 6/6o in 34, 6/24 in four, and 6/36 in the remaining four. All these eyes had terminal Stage III proliferative diabetic retinopathy or retinoschisis. The retention of vision in the treated group of "only eyes" is remarkably good; 27 eyes (64 per cent.) retained the original level of vision and 22 of these (52 per Miki, Fukuda, Kuzaya, Kosaka, and Nakao (I969) . In our treated series we also found that patients with diabetes of mature onset lost vision in a shorter time than the younger patients, but in both types the best results were obtained from the early treatment of groups of new vessels, although coagulation is necessarily more limited in older patients in the presence ofischaemic changes.
It seems, therefore, that photocoagulation has a definite place in delaying or preventing the onset of blindness in patients with proliferative diabetic retinopathy. It should, however, be emphasized that in this series the results have been obtained by meticulous observations coupled with precise photocoagulation by the same two ophthalmologists, with adequate resources for in-patient treatment. Summary (I) I74 eyes from 126 consecutive cases of proliferative diabetic retinopathy have been treated by repeated light coagulations and restriction of certain forms of physical activity. The results are compared with those in 59 "control" eyes from 42 patients previously documented.
(2) Using the parameter of the retention of the original visual acuity, the treated cases fared better than the controls, especially those eyes which were under observation for more than 3 years.
(3) In a group of 42 treated "only eyes" which had a potentially poor prognosis, being the surviving eyes of patients in whom the fellow eye was blind or was untreatable because of proliferative diabetic retinopathy, the retention of vision was considerably better than in an untreated series previously reported. 
